-
Signature
-
/s/ Brian Sandstrom, as Attorney-in-Fact
-
Stock symbol
-
MRNA
-
Transactions as of
-
Dec 17, 2021
-
Transactions value $
-
-$5,928,650
-
Form type
-
4
-
Date filed
-
12/21/2021, 03:06 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MRNA |
Common Stock |
Options Exercise |
$61.1K |
+5K |
|
$12.21* |
5K |
Dec 17, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$1.38M |
-5K |
-100% |
$275.68 |
0 |
Dec 17, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Options Exercise |
$142K |
+10K |
|
$14.22* |
10K |
Dec 20, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Options Exercise |
$61.1K |
+5K |
+50% |
$12.21* |
15K |
Dec 20, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$4.81M |
-15K |
-100% |
$320.97 |
0 |
Dec 20, 2021 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-14.29% |
$0.00 |
30K |
Dec 17, 2021 |
Common Stock |
5K |
$12.21 |
Direct |
F1, F2 |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10K |
-25.89% |
$0.00 |
28.6K |
Dec 20, 2021 |
Common Stock |
10K |
$14.22 |
Direct |
F1, F3 |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-16.67% |
$0.00 |
25K |
Dec 20, 2021 |
Common Stock |
5K |
$12.21 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Technical Operations and Quality Officer